1. Biotech IPO bonanza: Legend Biotech, Forma Therapeutics, Repare — COVID-19 could slow progress in reducing cancer death, NCI warns — ASCO 2020 news from Merck, AstraZeneca, Pfizer, more — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

zohydro

Discussion in 'Pernix' started by Anonymous, Jun 17, 2015 at 6:34 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Why would a dr write zohydro when norco is only $10? I'm interviewing with this company and I'm wondering if it's a good move for me. Thanks.
     

  2. Anonymous

    Anonymous Guest

    Lol!! The question you should really be asking is, "why would a doctor write Silenor 6mg instead of Generic 10mg Doxepin?" Good luck!
     
  3. Anonymous

    Anonymous Guest

    If you don't know the answer to this question already then save yourself some time and don't interview. You obviously have no clue.
     
  4. Anonymous

    Anonymous Guest

    For the same reason a doc would transition a patient from immediate release Roxicodone or Percocet to extended-release OxyContin. Convenience, better control, lower pill burden.

    But docs ain't the problem. Getting payers to support Zohydro is. That's were the problem is.

    If you have choices, don't sell this product. It's a tough market. If you need a job, give it a whirl, but realize you need to work really, really hard.
     
  5. Anonymous

    Anonymous Guest

    THANK YOU so much for your honesty!! I really appreciate you helping me. I don't know anything about this market and I can't afford to make a bad move to another company.
     
  6. anonymous

    anonymous Guest

    Ive been contacted about a job selling zohydro. How are the goals? obviously it must be a difficult sell because of all the generics on the market. How is it perceived by docs? do they see value in it? Any info on the subject would be appreciated.
     
  7. anonymous

    anonymous Guest

    see June 19th post.

    Tough market. No abuse deterrence in label. Other brands have better label or coming to market with better label. Won't be easy.
     
  8. anonymous

    anonymous Guest

     
  9. anonymous

    anonymous Guest

    BEST DRUG EVER....so glad we bought this it sure did change the company
     
  10. anonymous

    anonymous Guest

    BYE FELICIA